Artasensi A, Pedretti A, Vistoli G, Fumagalli L (2020) Type 2 diabetes mellitus: a review of multi-target drugs. Molecules 25(8):1987. https://doi.org/10.3390/molecules25081987

Article  CAS  PubMed  PubMed Central  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR et al (2023) 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023. Diabetes Care 46(Suppl 1):S140–S157. https://doi.org/10.2337/dc23-S009

Article  CAS  PubMed  Google Scholar 

Fang M, Wang D, Coresh J, Selvin E (2021) Trends in diabetes treatment and control in U.S. adults, 1999-2018. N Engl J Med 384(23):2219–2228. https://doi.org/10.1056/NEJMsa2032271

Article  PubMed  PubMed Central  Google Scholar 

Esposito K, Chiodini P, Bellastella G, Maiorino MI, Giugliano D (2012) Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes Obes Metab 14(3):228–233. https://doi.org/10.1111/j.1463-1326.2011.01512.x

Article  CAS  PubMed  Google Scholar 

Hirsch IB, Gaudiani LM (2020) Using insulin to treat poorly controlled type 2 diabetes in 2020. JAMA 323(23):2419–2420. https://doi.org/10.1001/jama.2020.1303

Article  PubMed  Google Scholar 

American Diabetes Association Professional Practice Committee (2025) 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025. Diabetes Care 48(Supplement_1):S181–S206. https://doi.org/10.2337/dc25-S009

Article  Google Scholar 

Umpierrez GE, Skolnik N, Dex T, Traylor L, Chao J, Shaefer C (2019) When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control. Diabetes Obes Metab 21(6):1305–1310. https://doi.org/10.1111/dom.13653

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holman RR, Farmer AJ, Davies MJ et al (2009) Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 361(18):1736–1747. https://doi.org/10.1056/NEJMoa0905479

Article  CAS  PubMed  Google Scholar 

Rodbard HW, Tripathy D, Vidrio Velázquez M, Demissie M, Tamer SC, Piletič M (2017) Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18-week, open-label, phase 3 trial (onset 3). Diabetes Obes Metab 19(10):1389–1396. https://doi.org/10.1111/dom.12955

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lasserson DS, Glasziou P, Perera R, Holman RR, Farmer AJ (2009) Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia 52(10):1990–2000. https://doi.org/10.1007/s00125-009-1468-7

Article  CAS  PubMed  Google Scholar 

Philis-Tsimikas A, Asong M, Franek E et al (2023) Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial. Lancet Diabetes Endocrinol 11(6):414–425. https://doi.org/10.1016/S2213-8587(23)00093-1

Article  CAS  PubMed  Google Scholar 

Semlitsch T (2020) Ultra-long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 11(11):CD005613. https://doi.org/10.1002/14651858.CD005613.pub4

Article  PubMed  Google Scholar 

Mannucci E, Caiulo C, Naletto L, Madama G, Monami M (2021) Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials. Endocrine 74(3):508–517. https://doi.org/10.1007/s12020-021-02889-6

Article  CAS  PubMed  Google Scholar 

Fullerton B, Siebenhofer A, Jeitler K et al (2018) Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus. Cochrane Database Syst Rev 12(12):CD013228. https://doi.org/10.1002/14651858.CD013228

Article  PubMed  Google Scholar 

Hutton B, Salanti G, Caldwell DM et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784. https://doi.org/10.7326/M14-2385

Article  PubMed  Google Scholar 

Shanaa A (2021) Rayyan - AI powered tool for systematic literature reviews. Available from https://www.rayyan.ai/. Accessed 16 Oct 2023

Higgins JPT, Li T, Deeks JJ (2023) Chapter 6: Choosing effect measures and computing estimates of effect. Available from https://training.cochrane.org/handbook/current/chapter-06#section-6-5-2-7. Accessed 11 Feb 2025

Sterne JAC, Savović J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898

Article  PubMed  Google Scholar 

Nikolakopoulou A, Higgins JPT, Papakonstantinou T et al (2020) CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLoS Med 17(4):e1003082. https://doi.org/10.1371/journal.pmed.1003082

Article  PubMed  PubMed Central  Google Scholar 

Balduzzi S, Rücker G, Nikolakopoulou A et al (2023) netmeta: An R package for network meta-analysis using frequentist methods. J Stat Softw 106(2):1–40. https://doi.org/10.18637/jss.v106.i02

Article  Google Scholar 

Harrer M, Cuijpers P, Furukawa TA, Ebert DD (2021) Doing meta-analysis with R: a hands-on guide. Chapman & Hall/CRC Press, New York

Book  Google Scholar 

Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JPT (2014) Evaluating the quality of evidence from a network meta-analysis. PLoS One 9(7):e99682. https://doi.org/10.1371/journal.pone.0099682

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chaimani A, Caldwell DM, Li T, Higgins JPT, Salanti G (2022) Chapter 11: Undertaking network meta-analyses. https://training.cochrane.org/handbook/current/chapter-11. Accessed 25 Mar 2024

Owens DR, Luzio SD, Sert-Langeron C, Riddle MC (2011) Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month “proof-of-concept” study. Diabetes Obes Metab 13(11):1020–1027. https://doi.org/10.1111/j.1463-1326.2011.01459.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anyanwagu U, Mamza J, Gordon J, Donnelly R, Idris I (2017) Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data. Diabet Med 34(12):1728–1736. https://doi.org/10.1111/dme.13518

Article  CAS  PubMed  Google Scholar 

Giugliano D, Chiodini P, Maiorino MI, Bellastella G, Esposito K (2016) Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Endocrine 51(3):417–428. https://doi.org/10.1007/s12020-015-0718-3

Article  CAS  PubMed  Google Scholar 

Wang C, Mamza J, Idris I (2015) Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabet Med 32(5):585–594. https://doi.org/10.1111/dme.12694

Article  CAS  PubMed  Google Scholar 

Bai R, Batra K, Yap C, Izuora K (2023) Diabetes-related outcomes with basal-bolus vs premixed insulin among veterans with type 2 diabetes: a single institutional retrospective study. Am J Med Sci 366(1):38–43. https://doi.org/10.1016/j.amjms.2023.04.003

Article  PubMed  Google Scholar 

Miyoshi H, Baxter M, Kimura T et al (2021) A real-world, observational study of the initiation, use, and effectiveness of basal-bolus or premixed insulin in Japanese people with type 2 diabetes. Diabetes Ther 12(5):1341–1357. https://doi.org/10.1007/s13300-021-01041-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Home PD, Dain M-P, Freemantle N et al (2015) Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents. Diabetes Res Clin Pract 108(2):350–359. https://doi.org/10.1016/j.diabres.2015.01.030

Article  PubMed  Google Scholar 

(1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131):837–853